Figure 1.
Mechanism of NaHS-induced reduction in infarct size in rabbits. Infarct-to-risk area ratio. *P < 0.05 vs. control group; #P < 0.05 vs. PostC group. PostC, postconditioning; DT2, PKG-I inhibitor; TAT, control peptide for DT2; 5-HD, mitoKATP channel inhibitor; Glibenclamide, mito/sarc KATP channel inhibitor; l-NAME, NOS inhibitor. Control (n = 8); PostC (n = 7); PostC + DT2 (n = 6); NaHS (n = 7); NaHS + DT2 (n = 6); NaHS + TAT (n = 6); NaHS + PostC (n = 6); NaHS + 5-HD (n = 10); NaHS + Glibenclamide (n = 9); NaHS + l-NAME (n = 6).